NPI | Name | Type | Address |
---|---|---|---|
Chidimma Nicholson |
Individual |
3551 Roger Brooke Dr Fort Sam Houston, TX |
|
Luz Drouillard |
Individual |
3551 Roger Brooke Dr San Antonio, TX |
|
DR. PHARMD Mary Miracle |
Individual |
19229 Mack Ave Ste 34 Grosse Pointe Woods, MI |
|
Grace Baek |
Individual |
1354 Aloha St Seattle, WA |
|
PHARMD Michael Robles |
Individual |
1959 Ne Pacific St Seattle, WA |
|
DR. PHARMD Forrest N Ridgway |
Individual |
1301 Palm Ave Jacksonville, FL |
|
PHARMD, BCOP Lauren Dawn Curry |
Individual |
750 Rose St Lexington, KY |
|
PHARMD Wei-hsuan Tai |
Individual |
3855 Health Sciences Dr La Jolla, CA |
|
PHARMD Donyika Ann Joseph |
Individual |
1515 Holcombe Blvd Houston, TX |
|
DR. PHARM.D Chin Kyong Kim |
Individual |
6851 Bowles Ct Dublin, OH |
|
PHARMD Mark Edward Jao |
Individual |
825 Eastlake Ave E Seattle, WA |
|
PHARMD Yuchih E Tang |
Individual |
3855 Health Sciences Dr La Jolla, CA |
|
DR. PHARMD Ashley Crawley |
Individual |
8901 Carti Way Little Rock, AR |
|
PHARMD Marijana Stefanovic |
Individual |
77 Lafayette Pl Greenwich, CT |
|
PHARMD/PH.D. Ji Sun |
Individual |
9452 Medical Center Dr Rm 1e314 La Jolla, CA |
|
DR. Sarah G Walden |
Individual |
3701 Broadway Oakland, CA |
|
RPH Elle Eunyounglee Kim |
Individual |
7300 N Fresno St Fresno, CA |
|
PHARMD John Ericson Margallo |
Individual |
757 Westwood Plz # B140 Los Angeles, CA |
|
DR. PHARMD, BCOP Maria Josefina Arella |
Individual |
3883 Airway Dr Ste 320 Santa Rosa, CA |
|
Adam Kahleifeh |
Individual |
1275 York Ave New York, NY |
Every health care provider, whether it’s a hospital, pharmacy, or individual specialist, must obtain their own NPI number. This identification number is unique and is assigned upon application. In tod...
Taxonomy Code | 1835X0200X |
Specialization | Oncology |
Display Name | Oncology Pharmacist |
Taxonomy Group | Pharmacy Service Providers |
Taxonomy Classification | Pharmacist |
Definition | A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases. |
Effective Date | September 30, 2009 |